Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

DNLI

Denali Therapeutics Inc.

Healthcare · Biotech

$20.98Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Denali Therapeutics Inc. shows recovering business momentum based on AlphaOS pipeline evidence.

TrajectoryRecovering

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

DNLI's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on DNLI.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Denali Therapeutics Inc. (DNLI) — events, not interpretation.

Event
Last session September 28, 2026 at $20.98.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Denali Therapeutics Inc. (DNLI)

Healthcare · Biotech

Investment Snapshot above is the primary AlphaOS analysis for Denali Therapeutics Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotech
Market cap:
$3.35B
Revenue:
$3.60M

DNLI earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Denali Therapeutics Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.